Related Experiment Video
Updated: May 8, 2025

Microdissection of Primary Renal Tissue Segments and Incorporation with Novel Scaffold-free Construct Technology
Published on: March 27, 2018
Cell therapy in kidney diseases: advancing treatments for renal regeneration
Amankeldi A Salybekov1, Aiman Kinzhebay1, Shuzo Kobayashi2
1Qazaq Institute of Innovative Medicine, Regenerative Medicine Division, Cell and Gene Therapy Department, Astana, Kazakhstan.
Abstract:
Kidney diseases, including acute kidney injury (AKI) and chronic kidney disease (CKD), pose a significant global health challenge, with high morbidity and mortality rates driven by rising prevalence of risk factors such as diabetes and hypertension. Current therapeutic strategies are often limited, prompting the exploration of advanced cell therapies as potential solutions. This review provides a comprehensive overview of the state of cell therapies in kidney disease, tracing the progression from preclinical studies to clinical applications. Recent studies highlited that cell-based interventions offer kidney-protective properties through mechanisms such as paracrine signaling, immune modulation, and direct tissue integration, demonstrating potential in both AKI and CKD settings. Despite promising results, challenges remain in optimizing cell therapy protocols, including cell sourcing, delivery methods, and long-term outcomes. Finally, the review addresses on efforts to enhance cell function, optimize dosing, and refine delivery techniques to improve clinical outcomes in kidney disease management.
Insights
Cell therapies show promise for kidney diseases like acute kidney injury (AKI) and chronic kidney disease (CKD). Research is advancing to overcome challenges in cell sourcing, delivery, and long-term outcomes for improved patient treatment.
Area of Science:
- Nephrology
- Regenerative Medicine
- Cell Therapy
Background:
- Kidney diseases (AKI, CKD) are a major global health issue.
- Diabetes and hypertension increase kidney disease risk.
- Current treatments for kidney disease are limited.
Purpose of the Study:
- To review the current state of cell therapies for kidney diseases.
- To explore preclinical and clinical advancements in cell-based kidney treatments.
- To identify challenges and future directions in kidney disease cell therapy.
Main Methods:
- Comprehensive literature review of cell therapy research in kidney disease.
- Analysis of preclinical studies and clinical trial data.
- Evaluation of mechanisms of action for cell-based interventions.
Main Results:
- Cell therapies demonstrate kidney protection via paracrine signaling, immune modulation, and tissue integration.
- Positive outcomes observed in both acute kidney injury (AKI) and chronic kidney disease (CKD) models.
- Cellular interventions offer potential for novel kidney disease management.
Conclusions:
- Cell therapy is a promising avenue for treating kidney diseases.
- Further research is needed to optimize cell sourcing, delivery, and long-term efficacy.
- Enhancing cell function and refining delivery techniques are key to improving clinical outcomes.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Dialysis
Acute kidney injury develops suddenly and can be caused by pre-renal causes (e.g., hypovolemia, shock), intrinsic renal causes (e.g., acute tubular necrosis), or post-renal causes (e.g., urinary obstruction). In contrast, chronic renal failure progresses gradually over time and is often...
Stem Cell Culture
iPS Cell Differentiation
Gene Therapy

